WallStreetZenWallStreetZen

NASDAQ: BDTX
Black Diamond Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Black Diamond Therapeutics revenue was $0.00 for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BDTX annual revenue was $70.0M, with Infinity% growth year-over-year.

BDTX past revenue growth

How has BDTX's revenue growth performed historically?

Company
-100%
Industry
238.67%
Market
37.91%
BDTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BDTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

BDTX revenue history

Current Revenue
$0.0
Current Earnings
-$43.2M
Current Profit Margin
0%

Be the first to know when BDTX announces revenue.

BDTX Revenue History By Year

BDTX Yearly RevenueBDTX RevenueBDTX ChangeBDTX Revenue Growth
2025-12-31$70.00MN/AN/A
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A

1 of 1

Black Diamond Therapeutics Revenue FAQ

What was BDTX's revenue last quarter?

On Invalid Date, Black Diamond Therapeutics (NASDAQ: BDTX) reported Q1 2026 revenue of $0.00 up 100% year over year. In the same quarter last year, Black Diamond Therapeutics's revenue was $70.00 million.

What was Black Diamond Therapeutics's revenue in 2025?

Black Diamond Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $70.00 million, a Infinity% increase year over year.

How much does Black Diamond Therapeutics make in a day?

Based on Black Diamond Therapeutics annual revenue for the past five years, BDTX makes an average of $38,356.16 per day.

What was Black Diamond Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Black Diamond Therapeutics's revenue has grown -100% year over year. This is 338.67 percentage points lower than the US Biotechnology industry revenue growth rate of 238.67%. Black Diamond Therapeutics's revenue in the past year totaled $0.00.

How much does Black Diamond Therapeutics make in a year?

Black Diamond Therapeutics's revenue by year for the past five years is:
  • Black Diamond Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $70.00 million, a Infinity% increase year over year.
  • Black Diamond Therapeutics's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
  • Black Diamond Therapeutics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Black Diamond Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Black Diamond Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.